Multimedia
Video
Ari Green, MD
Dr. Green, Chief of the Division of Neuroinflammation and Glial Biology at the University of California, San Francisco, discusses the...
Conference Coverage
VIDEO: Teriflunomide and dimethyl fumarate are comparable in relapsing-remitting MS
SAN DIEGO – Small study of oral drugs finds they’re similar in terms of efficacy and adverse effects, and both can be used “with equal confidence...
Video
Adil Harroud, MD
At the ACTRIMS 2018 Forum, Dr. Harroud describes his investigation of the potential link between age at puberty onset and risk of MS....
Conference Coverage
VIDEO: Advanced practice providers take on many roles in MS care
SAN DIEGO – Survey finds most MS advanced practice providers are highly satisfied with their jobs, patients, and colleagues.
Conference Coverage
VIDEO: Managing the alemtuzumab paradox
SAN DIEGO – Dr. Alasdair Coles explains the best management approach for this “high risk, high gain” drug.
Conference Coverage
VIDEO: Oral ozanimod shows promise for relapsing MS
SAN DIEGO – The drug is currently being evaluated by the Food and Drug Administration for relapsing multiple sclerosis.
Conference Coverage
VIDEO: Efficacy of DMTs decreases with age
SAN DIEGO – A meta-analysis offers new insights into the age-dependent efficacy of multiple sclerosis treatments.
Conference Coverage
VIDEO: New MS ambulatory measure could fill clinical gap
SAN DIEGO – Dr. Emily Evans explains how the single-item instruments measure up to existing ambulatory scales.
Conference Coverage
VIDEO: Alemtuzumab associated with long-term MS control in TOPAZ study
SAN DIEGO – Extension study reveals durable benefit at 7 years.
Conference Coverage
VIDEO: Could targeting gut dysbiosis in MS prevent disease?
SAN DIEGO – Transgenic mouse studies lead to questions of altering gut flora to prevent disease in people at high risk for multiple sclerosis.
